Search Results

There are 1329 results for: content related to: Low rates of naturally occurring resistant variants to the NS5A inhibitor daclatasvir in HCV-1 null responders

  1. You have free access to this content
    Deep sequencing analysis of variants resistant to the non-structural 5A inhibitor daclatasvir in patients with genotype 1b hepatitis C virus infection

    Hepatology Research

    Volume 44, Issue 14, December 2014, Pages: E360–E367, Mika Miura, Shinya Maekawa, Mitsuaki Sato, Nobutoshi Komatsu, Akihisa Tatsumi, Shinichi Takano, Fumitake Amemiya, Yasuhiro Nakayama, Taisuke Inoue, Minoru Sakamoto and Nobuyuki Enomoto

    Article first published online : 10 APR 2014, DOI: 10.1111/hepr.12316

  2. You have full text access to this OnlineOpen article
    All-Oral 12-Week Treatment With Daclatasvir Plus Sofosbuvir in Patients With Hepatitis C Virus Genotype 3 Infection: ALLY-3 Phase 3 Study

    Hepatology

    Accepted manuscript online: 23 JAN 2015, David R. Nelson, James N. Cooper, Jacob P. Lalezari, Eric Lawitz, Paul J. Pockros, Norman Gitlin, Bradley F. Freilich, Ziad H. Younes, William Harlan, Reem Ghalib, Godson Oguchi, Paul J. Thuluvath, Grisell Ortiz-Lasanta, Mordechai Rabinovitz, David Bernstein, Michael Bennett, Trevor Hawkins, Natarajan Ravendhran, Aasim M. Sheikh, Peter Varunok, Kris V. Kowdley, Delphine Hennicken, Fiona McPhee, Khurram Rana, Eric A. Hughes and on behalf of the ALLY-3 Study Team

    DOI: 10.1002/hep.27726

  3. You have free access to this content
    Resistance analysis of hepatitis C virus genotype 1 prior treatment null responders receiving daclatasvir and asunaprevir

    Hepatology

    Volume 58, Issue 3, September 2013, Pages: 902–911, Fiona McPhee, Dennis Hernandez, Fei Yu, Joseph Ueland, Aaron Monikowski, Arlene Carifa, Paul Falk, Chunfu Wang, Robert Fridell, Timothy Eley, Nannan Zhou and David Gardiner

    Article first published online : 16 JUL 2013, DOI: 10.1002/hep.26388

  4. You have free access to this content
    New horizons in hepatitis C antiviral therapy with direct-acting antivirals

    Hepatology

    Volume 58, Issue 1, July 2013, Pages: 428–438, Alessio Aghemo and Raffaele De Francesco

    Article first published online : 31 MAY 2013, DOI: 10.1002/hep.26371

  5. You have free access to this content
    Reply:

    Hepatology

    Volume 57, Issue 5, May 2013, Pages: 2087–2088, Jin-Hua Sun, Min Gao, Susan Roberts and Robert Fridell

    Article first published online : 23 APR 2013, DOI: 10.1002/hep.26381

  6. Novel Therapeutic Approaches for Hepatitis C

    Clinical Pharmacology & Therapeutics

    Volume 95, Issue 1, January 2014, Pages: 78–88, JS Au and PJ Pockros

    Article first published online : 19 DEC 2013, DOI: 10.1038/clpt.2013.206

  7. You have free access to this content
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Article first published online : 1 OCT 2012, DOI: 10.1002/hep.26040

  8. You have free access to this content
    Poster Session 4: Hepatitis C: New Agents (Not Approved)

    Hepatology

    Volume 60, Issue S1, October 2014, Pages: 1128A–1161A,

    Article first published online : 1 OCT 2014, DOI: 10.1002/hep.27533

  9. Current prospects for interferon-free treatment of hepatitis C in 2012

    Journal of Gastroenterology and Hepatology

    Volume 28, Issue 1, January 2013, Pages: 38–45, Catherine AM Stedman

    Article first published online : 19 DEC 2012, DOI: 10.1111/jgh.12028

  10. You have free access to this content
    Dual therapy with the nonstructural protein 5A inhibitor, daclatasvir, and the nonstructural protein 3 protease inhibitor, asunaprevir, in hepatitis C virus genotype 1b–infected null responders

    Hepatology

    Volume 55, Issue 3, March 2012, Pages: 742–748, Kazuaki Chayama, Shoichi Takahashi, Joji Toyota, Yoshiyasu Karino, Kenji Ikeda, Hiroki Ishikawa, Hideaki Watanabe, Fiona McPhee, Eric Hughes and Hiromitsu Kumada

    Article first published online : 30 JAN 2012, DOI: 10.1002/hep.24724

  11. You have free access to this content
    How to optimize current therapy in hepatitis C virus genotype 1 patients. Predictors of response to interferon-based therapy with second wave direct acting antivirals

    Liver International

    Volume 35, Issue s1, January 2015, Pages: 18–20, Lawrence Serfaty

    Article first published online : 22 DEC 2014, DOI: 10.1111/liv.12722

  12. You have free access to this content
    Drug-induced immunoallergic hepatitis during combination therapy with daclatasvir and asunaprevir

    Hepatology

    Volume 61, Issue 1, January 2015, Pages: 400–401, Yohei Fujii, Yoshihito Uchida and Satoshi Mochida

    Article first published online : 15 DEC 2014, DOI: 10.1002/hep.27559

  13. You have free access to this content
    Interferon free therapy with direct acting antivirals for HCV

    Liver International

    Volume 33, Issue s1, February 2013, Pages: 93–104, Tarik Asselah and Patrick Marcellin

    Article first published online : 3 JAN 2013, DOI: 10.1111/liv.12076

  14. Interferon-α/β for treatment of chronic hepatitis C infection in the era of direct-acting antiviral agents

    Hepatology Research

    Volume 44, Issue 4, April 2014, Pages: 371–376, Masaru Enomoto, Akihiro Tamori, Yoshiki Murakami and Norifumi Kawada

    Article first published online : 23 JAN 2014, DOI: 10.1111/hepr.12289

  15. Preclinical Pharmacokinetics and In Vitro Metabolism of Asunaprevir (BMS-650032), a Potent Hepatitis C Virus NS3 Protease Inhibitor

    Journal of Pharmaceutical Sciences

    Kathleen W. Mosure, Jay O. Knipe, Marc Browning, Vinod Arora, Yue-Zhong Shu, Thomas Phillip, Fiona Mcphee, Paul Scola, Anand Balakrishnan, Matthew G. Soars, Kenneth Santone and Michael Sinz

    Article first published online : 28 JAN 2015, DOI: 10.1002/jps.24356

  16. Hepatitis C therapy in non-genotype 1 patients: the near future

    Journal of Viral Hepatitis

    Volume 19, Issue 8, August 2012, Pages: 525–536, C. Wartelle-Bladou, G. Le Folgoc, M. Bourlière and L. Lecomte

    Article first published online : 4 JUL 2012, DOI: 10.1111/j.1365-2893.2012.01634.x

  17. Emergence of resistant variants detected by ultra-deep sequencing after asunaprevir and daclatasvir combination therapy in patients infected with hepatitis C virus genotype 1

    Journal of Viral Hepatitis

    Volume 22, Issue 2, February 2015, Pages: 158–165, K. Kosaka, M. Imamura, C. N. Hayes, H. Abe, N. Hiraga, S. Yoshimi, E. Murakami, T. Kawaoka, M. Tsuge, H. Aikata, D. Miki, H. Ochi, H. Matsui, A. Kanai, T. Inaba and K. Chayama

    Article first published online : 19 JUN 2014, DOI: 10.1111/jvh.12271

  18. Advances in interferon-free hepatitis C therapy: 2014 and beyond

    Hepatology

    Volume 59, Issue 4, April 2014, Pages: 1641–1644, Souvik Sarkar and Joseph K. Lim

    Article first published online : 3 MAR 2014, DOI: 10.1002/hep.27055

  19. You have free access to this content
    HCV Therapy: The Developmental Pipeline

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 429A–447A,

    Article first published online : 15 OCT 2013, DOI: 10.1002/hep.26845

  20. You have full text access to this OnlineOpen article
    Emerging therapies for the treatment of hepatitis C

    EMBO Molecular Medicine

    Volume 6, Issue 1, January 2014, Pages: 4–15, Christian M Lange, Ira M Jacobson, Charles M Rice and Stefan Zeuzem

    Article first published online : 16 SEP 2013, DOI: 10.1002/emmm.201303131